Valencia Nutrition Ltd
Incorporated in 2013, Valencia Nutrition Ltd is in the business of developing, manufacturing, sales & distribution of nutraceutical products[1]
- Market Cap ₹ 126 Cr.
- Current Price ₹ 74.5
- High / Low ₹ 78.8 / 35.8
- Stock P/E 118
- Book Value ₹ 21.5
- Dividend Yield 0.00 %
- ROCE 5.85 %
- ROE 6.20 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
Cons
- Stock is trading at 3.46 times its book value
- Earnings include an other income of Rs.0.65 Cr.
- Company has high debtors of 279 days.
- Working capital days have increased from 385 days to 734 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Fast Moving Consumer Goods Fast Moving Consumer Goods Beverages Other Beverages
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.07 | 0.39 | 0.73 | 0.41 | 1.42 | 2.37 | 0.95 | 0.00 | 1.46 | 1.34 | 8.47 | |
0.51 | 1.32 | 1.61 | 2.16 | 1.50 | 3.58 | 6.54 | 3.81 | 0.58 | 2.65 | 2.95 | 7.70 | |
Operating Profit | -0.51 | -1.25 | -1.22 | -1.43 | -1.09 | -2.16 | -4.17 | -2.86 | -0.58 | -1.19 | -1.61 | 0.77 |
OPM % | -1,785.71% | -312.82% | -195.89% | -265.85% | -152.11% | -175.95% | -301.05% | -81.51% | -120.15% | 9.09% | ||
0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.08 | 0.00 | -0.49 | 0.00 | 0.00 | 0.31 | 0.65 | |
Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | 0.04 | 0.09 | 0.01 | 0.00 | 0.03 | 0.13 |
Depreciation | 0.01 | 0.04 | 0.04 | 0.04 | 0.06 | 0.06 | 0.12 | 0.13 | 0.08 | 0.07 | 0.05 | 0.21 |
Profit before tax | -0.52 | -1.29 | -1.26 | -1.46 | -1.16 | -2.14 | -4.33 | -3.57 | -0.67 | -1.26 | -1.38 | 1.08 |
Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
-0.52 | -1.29 | -1.26 | -1.47 | -1.16 | -2.14 | -4.34 | -3.58 | -0.66 | -1.26 | -1.38 | 1.07 | |
EPS in Rs | -129.00 | -126.00 | -29.40 | -19.33 | -30.57 | -3.10 | -2.56 | -0.47 | -0.90 | -0.99 | 0.63 | |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | 62% |
5 Years: | 29% |
3 Years: | % |
TTM: | 532% |
Compounded Profit Growth | |
---|---|
10 Years: | 11% |
5 Years: | 18% |
3 Years: | 54% |
TTM: | 178% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 25% |
3 Years: | 96% |
1 Year: | 26% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | 6% |
Balance Sheet
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 0.02 | 0.04 | 0.06 | 0.19 | 0.25 | 0.28 | 5.59 | 5.59 | 5.59 | 5.59 | 5.59 | 16.98 |
Reserves | 0.05 | 0.29 | 0.15 | -1.22 | 0.87 | 0.38 | -0.75 | -4.33 | -4.99 | -6.25 | -7.64 | 19.60 |
0.08 | 0.08 | 0.08 | 0.99 | 0.18 | 0.18 | 0.65 | 0.56 | 0.60 | 2.18 | 5.34 | 1.49 | |
0.08 | 0.10 | 0.23 | 0.37 | 0.32 | 0.57 | 1.32 | 1.86 | 1.24 | 1.26 | 2.71 | 0.35 | |
Total Liabilities | 0.23 | 0.51 | 0.52 | 0.33 | 1.62 | 1.41 | 6.81 | 3.68 | 2.44 | 2.78 | 6.00 | 38.42 |
0.04 | 0.06 | 0.08 | 0.09 | 0.09 | 0.11 | 1.44 | 1.41 | 0.22 | 0.15 | 2.32 | 6.19 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.93 |
0.19 | 0.45 | 0.44 | 0.24 | 1.53 | 1.30 | 5.34 | 2.27 | 2.22 | 2.63 | 3.68 | 29.30 | |
Total Assets | 0.23 | 0.51 | 0.52 | 0.33 | 1.62 | 1.41 | 6.81 | 3.68 | 2.44 | 2.78 | 6.00 | 38.42 |
Cash Flows
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00 | -1.23 | -1.12 | -1.28 | -2.56 | -4.10 | -2.49 | -1.35 | -1.55 | -0.76 | -19.44 | |
0.00 | 0.00 | -0.06 | -0.05 | -0.05 | -0.01 | -2.05 | -0.09 | 1.12 | 0.00 | -2.22 | -6.46 | |
0.00 | 0.00 | 1.14 | 1.15 | 2.47 | 1.68 | 8.89 | -0.17 | 0.42 | 1.58 | 3.13 | 33.57 | |
Net Cash Flow | 0.00 | 0.00 | -0.15 | -0.03 | 1.14 | -0.89 | 2.73 | -2.76 | 0.20 | 0.03 | 0.15 | 7.67 |
Ratios
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 208.57 | 149.74 | 40.00 | 17.80 | 33.42 | 3.08 | 7.68 | 72.50 | 264.22 | 279.24 | ||
Inventory Days | 851.67 | 214.71 | 62.93 | 124.43 | 112.54 | 114.68 | 16.50 | 2,920.00 | 200.39 | 143.54 | 216.24 | |
Days Payable | 182.50 | 118.09 | 132.16 | 82.95 | 63.87 | 48.09 | 115.48 | 8,030.00 | 76.34 | 49.21 | 10.57 | |
Cash Conversion Cycle | 877.74 | 246.36 | -29.22 | 59.28 | 82.08 | 69.67 | -91.30 | 196.55 | 358.54 | 484.91 | ||
Working Capital Days | 521.43 | 149.74 | -70.00 | 53.41 | 102.82 | 40.04 | -115.26 | 300.00 | 119.85 | 734.31 | ||
ROCE % | -460.71% | -360.00% | -1,168.00% | -180.95% | -200.00% | -135.55% | -81.26% | -43.71% | -92.65% | -56.13% | 5.85% |
Documents
Announcements
- Record Date For 12Th AGM To Be Held On September 27, 2025, At 11:00 A.M. 4 Sep
- Book Closure For 12Th AGM Held On September 27, 2025, At 11:00 A.M. 4 Sep
-
Reg. 34 (1) Annual Report.
4 Sep - Valencia Nutrition files Annual Report FY2024-25; AGM Sep 27, 2025 hybrid (Mumbai and VC).
- Shareholders Meeting/ Annual General Meeting (''''AGM'''') Of Valencia Nutrition Limited Is To Be Held On Saturday, September 27, 2024 At 11:00 A.M. In Hybrid Mode In Person And Through Electronic Mode (VC Or OAVM) 4 Sep
-
Board Meeting Outcome for Outcome Of Board Meeting Held On Tuesday, September 02, 2025 At 03:00 P.M. And Concluded At 04:00 P.M
2 Sep - Board approved MD/WTD/IDs reappointments, material RPT, raise borrowings/create charges, AGM Sept 27, 2025.
Business Overview:[1][2]
VNL is a BSE Start Up Listed Corporate Company since January 2020. It is an applied biotechnology company focused on research, developing & marketing Ready to Drink nutraceuticals, Ready-to-Mix nutraceuticals (Ease Out Sachets) viz. AL Cans, Sachets, PET bottles, PET Cans, Tetra Pack, and Refreshment Mints etc. to prevent or manage lifestyle related diseases